Clinical Trials Browser

OTHER × BCG Vaccine × Dermatologic × Clear all

NCT01838200 2022-10-12

Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma

Phase 1 Terminated

5 enrolled 12 charts

Melanoma